Questions? 858.450.2800 Schedule a: DEMO
SUDOSCAN® User: LOGIN
Skip to content
  • About SUDOSCAN® USA
    • Device Information
    • In your practice
    • Company
  • Research, News & Events
  • About Us
  • Contact Us
  • SUDOSCAN® Shop
  • Log in
  • Facebook
  • YouTube
  • Twitter
  • LinkedIn
Cart


Subtotal
$0.00
Shipping, taxes, and discount codes calculated at checkout.
Your cart is currently empty.
SUDOSCAN SUDOSCAN SUDOSCAN SUDOSCAN
  • About SUDOSCAN® USA
    • Device Information
    • In your practice
    • Company
  • Research, News & Events
  • About Us
  • Contact Us
  • SUDOSCAN® Shop
Log in Cart

Confirm your age

Are you 18 years old or older?

Come back when you're older

Sorry, the content of this store can't be seen by a younger audience. Come back when you're older.

Access Denied
IMPORTANT! If you’re a store owner, please make sure you have Customer accounts enabled in your Store Admin, as you have customer based locks set up with EasyLockdown app. Enable Customer Accounts
Home / SCIENTIFIC NEWS / SUDOSCAN® and COVID-19
Infectious disease · News · Feb 18, 2023

SUDOSCAN® and COVID-19

SUDOSCAN® and COVID-19

Sudomotor dysfunction in patients
recovered from COVID-19


Anand Hinduja, Abdul Moutairou, Jean-Henri Calvet
Article title: Sudomotor dysfunction in patients recovered from COVID-19.
Neurophysiologie Clinique/Clinical Neurophysiology, Feb 2021.

Dysautonomia has been reported in COVID-19 infection. Very recently an observational study, performed by Hinduja et al, from Aarti Clinic, Kharghar, Navi Mumbai, India, involved 50 patients who had recovered from COVID-19 and were seen within 3 months post-infection in an outpatient clinic for fatigue or various neurological symptoms.

The NHS (National Health Service) questionnaire for neurological symptoms was completed and electrochemical skin conductance was measured using SUDOSCAN.

Presence of sweat dysfunction (decrease in FESC – Feet Electrochemical Skin Conductance) was observed in 26% of patients, while 6% had severe sweat dysfunction.

These patients with decrease in FESC more frequently reported at least one motor, sensory or autonomic symptom (p = 0.04). See Table 1.

Sudomotor dysfunction in patients recovered from COVID-19
Table 1: Details of symptoms (sensory, motor and autonomic) reported by the patients
in the whole population and according to the presence (FESC <60 µS) or absence
of sudomotor dysfunction (FESC ≥60 µS).

This preliminary observational study reveals that more than 25 % of patients who recovered from COVID-19 and seen in an outpatient clinic, had sweat dysfunction generally reflecting dysautonomia, which could have severe consequences and must be monitored during follow-up.

These findings must be confirmed in a larger population with additional testing but underline the necessity of enhancing screening of dysautonomia in this population of patients recovered from COVID-19.

In this way it could be helpful to test the patients recovered from COVID-19 using SUDOSCAN a very simple and rapid test.

Share Share on Facebook Tweet Tweet on Twitter Pin it Pin on Pinterest

Back to SCIENTIFIC NEWS

You may also like View all

Jul 17 2023
Example blog post
Jul 17 2023
Example blog post
Jul 17 2023
Example blog post
Invalid password
Enter
More information about SUDOSCAN®?

Learn why Physicians use SUDOSCAN® during the diagnostic evaluation of Small Fiber and Autonomic Neuropathy for the early detection of potentially treatable diseases. Discover why your patients will appreciate a non-invasive test to monitor their disease and treatment outcome.

Contact Us
Schedule a SUDOSCAN® DEMO

SUDOSCAN® is a patented technology that evaluates sweat gland function, which is controlled by small nerves like some of those involved in pain sensation. Discover how SUDOSCAN® technology is less Invasive and more reliable.

Schedule a DEMO
SUDOSCAN

SUDOSCAN® is a privately-owned French medical device company.

Created in June 2005, its corporate headquarters are located in Paris, France; the company is also present in San Diego, CA, USA and in Beijing, China.

  • Facebook
  • YouTube
  • Twitter
  • LinkedIn

Main menu

  • About SUDOSCAN® USA
  • Research, News & Events
  • About Us
  • Contact Us
  • SUDOSCAN® Shop

Shop SUDOSCAN

  • Sudoscan 3
  • Mobility Kit
  • Benefect Botanical Decon 30
  • Kimtech Science™ Precision Wipes
  • SUDOSCAN® USB Drive

Resources

  • For Physicians
  • For Patients
  • SUDOSCAN® Articles
  • Marketing Material
  • SUDOSCAN® Videos
  • SUDOSCAN® Image Gallery

CONTACT INFO:

OFFICE : SUDOSCAN Inc. 8525 Gibbs Dr. Suite 304 - San Diego, CA 92123

PHONE: +1 858 450 2800

Promotional Communication. The medical devices SUDOSCAN® is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12

Language

  • English
  • Français

Currency

  • Canada (CAD $)
  • United States (USD $)
  • American Express
  • Apple Pay
  • Diners Club
  • Discover
  • Google Pay
  • Mastercard
  • Shop Pay
  • Visa
© 2023 SUDOSCAN Powered by Shopify
SUDOSCAN® and COVID-19